Cedia(R) Theophylline Assay/Modification
FDA 510(k) K905521 · Microgenics Corp.
510(k) numberK905521
Submission
- Device name
- Cedia(R) Theophylline Assay/Modification
- Applicant
- Microgenics Corp.
Concord, CA, US - Received
- December 7, 1990
- Decision date
- December 26, 1990
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
Device classification
- Product code
- LER – Fluorescent Immunoassay, Theophylline
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 862.3880
- Specialty
- Clinical Toxicology
Other 510(k)s with product code LER
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K942192 | Theophylline Fpia Reagent Set and CalibratorsLER · Traditional | Sigma Diagnostics, Inc. | 07/13/1994SE |
| K882570 | Turbox Theophylline AssayLER · Traditional | Unipath , Ltd. | 11/10/1988SE |
| K864409 | Immpulse Coated Tube Theophylline Assay ReagentsLER · Traditional | Sclavo, Inc. | 12/22/1986SE |
| K863475 | Theofast(Tm) Test PackageLER · Traditional | 3M Company | 11/05/1986SE |
| K842585 | Theophylline Kit Fluorescence Polariza-LER · Traditional | Windsor Laboratories, Inc. | 09/26/1984SE |
| K840758 | Immpulse Theophylline Assay ReagentsLER · Traditional | Paragon Diagnostics, Inc. | 04/04/1984SE |
| K833070 | TDX TheophyllineLER · Traditional | Abbott Laboratories | 11/14/1983SE |
| K831514 | Amwa Tda Theophylline TestLER · Traditional | Miles Laboratories, Inc. | 06/30/1983SE |
| K823576 | Cobas Standard for Total ProteinLER · Traditional | Hoffmann-La Roche, Inc. | 01/07/1983SE |
| K820397 | Amerifluor Theophylline Fluorescent ImmLER · Traditional | American Diagnostic Corp. | 03/02/1982SE |
More from American Diagnostic Corp.
| 510(k) | Device | Decision |
|---|---|---|
| K243498 | Alinity c Benzodiazepines Reagent KitJXM · Special | 12/11/2024SE |
| K240670 | DRI Ecstasy Plus AssayDKZ · Special | 10/30/2024SE |
| K231020 | Alinity c Tricyclic Antidepressants Reagent KitLFH · Traditional | 11/17/2023SE |
| K231007 | CEDIA Heroin Metabolite (6-AM) AssayDJG · Traditional | 09/27/2023SE |
| K213875 | DRI TM Tricyclics Serum Tox AssayLFH · Traditional | 12/21/2022SE |
| K211973 | DRI Cocaine Metabolite AssayDIO · Traditional | 09/24/2021SE |
| K192943 | CEDIA Heroin Metabolite (6-AM) assayDJG · Traditional | 12/16/2019SE |
| K190968 | CEDIA Benzodiazepine AssayJXM · Traditional | 12/09/2019SE |
| K181499 | DRI Cocaine Metabolite AssayDIO · Traditional | 07/06/2018SE |
| K173963 | DRI Benzodiazepine AssayJXM · Traditional | 02/21/2018SE |
Questions and answers
When was Cedia(R) Theophylline Assay/Modification cleared by the FDA?
Cedia(R) Theophylline Assay/Modification (K905521) received a 510(k) decision of Substantially Equivalent on December 26, 1990, 19 days after the submission was received.
What is the product code of K905521?
The FDA product code is LER – Fluorescent Immunoassay, Theophylline, a Class II (moderate risk) device regulated under 21 CFR 862.3880.